2019
$108M
from 12 investors over 12 rounds
Asher Biotherapeutics raised $108M on September 1, 2021
Investors: Logos Global Management, LP, Mission BioCapital, Third Rock Ventures, Wellington Management, RA Capital Management, L.P., The Invus Group and Marshall Wace
Asher Biotherapeutics raised $55M on March 23, 2021
Investors: The Invus Group, Third Rock Ventures, MBC Biolabs and Y Combinator
Asher Biotherapeutics raised $150K on August 19, 2019
Investors: Y Combinator